Recon: Gruber and Krause to leave CBER; Sanofi refiles with FTC on $3.2B Translate Bio buyout
ReconKari Oakes
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyReconKari OakesBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesPharmaceuticalsRegulatory Intelligence/Policy